Welcome!

News Feed Item

Plandai Biotechnology Management Discusses Progress of Company's Cannabis Extracts

NEW YORK, NY -- (Marketwired) -- 03/28/14 -- Last month Plandaí Biotechnology, Inc. (OTCQB: PLPL) closed a licensing agreement with Diego Pellicer, Inc. that will allow the company to use the Diego Pellicer name for its Phytofare™ cannabis extract in medical and pharmaceutical marijuana applications. Plandaí will produce the new Diego Pellicer Gold™ extracts in both capsules and cannabis oil (for vapor use) in Pheroid™ and non-Pheroid™ versions to appeal to the broadest range of medicinal consumers.

Stock Market Media Group (SMMG), a full service research and content development investor relations firm, asked Plandaí's management about the company's journey to introduce cannabis extracts to the market.

SMMG: Where is Plandai in the process of adding cannabis products?

Plandaí: "We are doing several things simultaneously. First, we're reviewing the various strains of cannabis and selecting one that we feel will have the best chemical profile for what we want to accomplish with the extract.

We're also working in Washington to ensure that we have live plant matter available for testing later in the year. Finally, we are engineering a CRS hydrodynamic processing and extraction system and constructing a laboratory in Washington that will make the initial extract for testing."

SMMG: What has been completed in the process and what is left to complete?

Plandaí: "The initial steps involved determining if we could even make a cannabis extract. This involved a review of the legal environment, the physical properties of the plant, and the chemical properties of the plant. We then needed to hire a small team that could 1) Select the correct strain, 2) Establish cultivation protocols, 3) Reach out to investigational institutions to begin lining up clinical trials, and 4) Adapt our current extraction system to be able to process cannabis. All of these things have happened.

We expect to finalize terms with a cultivation facility in the coming weeks so that we have suitable established plants in adequate quantities by this fall to begin making sample extract. Remember, we must use live plant material and we must use a specific and reproducible strain. We can't just go into a shop and buy dry leaf. Working with local growers, we need to document their cultivation techniques, fertilizer, etc. All of these things can impact the chemical profile. So, we need to manage the process to ensure that we have the correct chemical profile.

Concurrently, we will be building a small-scale lab so that we can produce our first cannabinoid extract. This will then need to be tested to get a chemical profile. We then need to test it for bioavailability and establish dosage parameters. Only then can we start testing for specific medical properties and benefits."

SMMG: What role will both the hydrodynamic sheering process and Pheroid® play in the production of extracts?

Plandaí: "The hydrodynamic sheering process is what breaks down and separates the plant structures, giving us increased bioavailability as well as allowing us to maximize the amount of phytonutrients we extract. All of our products will go through this process. The specific processing challenges we face with cannabis are releasing THC and CBD from the viscous cannabis oil and in the process reducing the articles to a high percentage of nano from the current ratio of 250-350mg. To achieve this, new formulated liquids will be used in the processing cycle.

The Pheroid® brings in certain additional properties which, depending on the individual may be considered advantageous or disadvantageous.

Essentially, the Pheroid® will entrap the cannabinoids until they reach the cells. This means that the THC will not metabolize in the blood stream, thus conceivably eliminating the psychoactive effects. We believe that we will be able to deliver a meaningful dosage of cannabinoids without the accompanying 'high.'

This will be ideal for patients with neural disorders and diseases. Some conditions require or prefer the metabolized THC and welcome the associated psychoactive effects. Thus, we expect to develop and test both a Pheroid® and non-Pheroid® version of the product."

SMMG: Where will these extracts be sold?

Plandaí: "We do not plan on having retail locations or selling directly to consumers. We are an ingredient manufacturer for nutraceutical and pharmaceutical applications. We will produce our extracts and then look to sell them to manufacturers of finished goods or into medicinal applications."

SMMG: What role, if any, will your South African plantation and manufacturing facility play in the future of your cannabis extract?

Plandaí: "Presently, South African law prohibits the cultivation of cannabis and furthermore it would be impossible to legally export or import any cannabis-based products or extracts. Our South Africa estate and factory is set up exclusively for processing our Phytofare™ Catechin Complex, which is made from green tea, though eventually we expect to also produce a citrus complex at this same facility. So, our South Africa operations will not be involved in any way for the foreseeable future. Until we are through with our research and animal trials, it is premature to speculate on when, if, or where we will produce a commercial cannabis extract, but we will only be involved if we can be assured that we are complying with all Federal and state laws.

As we recently announced, however, an appeal was made on our behalf to the South African legislature to grant Plandaí a special dispensation, or waiver, allowing us to produce and test a cannabinoid Phytofare™ extract for human clinical trials. In addition, legislation has recently been introduced in South Africa to permit medical marijuana research. Should this legislation pass, or should the government grant us special dispensation, it could open up the door to advancing medical research on an accelerated basis. We will know more in the coming months and will keep our shareholders apprised of any developments on this front."

About Stock Market Media Group

SMMG is a full service IR firm specializing in Research and Content Development. It offers a platform for corporate stories to unfold through the media with Reports, Interviews and Articles. SMMG is compensated for Plandaí articles, reports and interviews by a third party who reserves the right to sell securities at any time before, during, or after the publication of this article. To date, SMMG has received total compensation of $36,290, for content related to Plandaí. For more information and to read full disclaimers and disclosures: www.stockmarketmediagroup.com/disclaimer.

Add to Digg Bookmark with del.icio.us Add to Newsvine

Contact:
Stock Market Media Group
Email Contact

More Stories By Marketwired .

Copyright © 2009 Marketwired. All rights reserved. All the news releases provided by Marketwired are copyrighted. Any forms of copying other than an individual user's personal reference without express written permission is prohibited. Further distribution of these materials is strictly forbidden, including but not limited to, posting, emailing, faxing, archiving in a public database, redistributing via a computer network or in a printed form.

Latest Stories
SYS-CON Events announced today that Keisoku Research Consultant Co. will exhibit at the Japan External Trade Organization (JETRO) Pavilion at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Keisoku Research Consultant, Co. offers research and consulting in a wide range of civil engineering-related fields from information construction to preservation of cultural properties. For more information, vi...
SYS-CON Events announced today that Interface Corporation will exhibit at the Japan External Trade Organization (JETRO) Pavilion at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Interface Corporation is a company developing, manufacturing and marketing high quality and wide variety of industrial computers and interface modules such as PCIs and PCI express. For more information, visit http://www.i...
SYS-CON Events announced today that Fusic will exhibit at the Japan External Trade Organization (JETRO) Pavilion at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Fusic Co. provides mocks as virtual IoT devices. You can customize mocks, and get any amount of data at any time in your test. For more information, visit https://fusic.co.jp/english/.
With the rise of DevOps, containers are at the brink of becoming a pervasive technology in Enterprise IT to accelerate application delivery for the business. When it comes to adopting containers in the enterprise, security is the highest adoption barrier. Is your organization ready to address the security risks with containers for your DevOps environment? In his session at @DevOpsSummit at 21st Cloud Expo, Chris Van Tuin, Chief Technologist, NA West at Red Hat, will discuss: The top security r...
SYS-CON Events announced today that TMC has been named “Media Sponsor” of SYS-CON's 21st International Cloud Expo and Big Data at Cloud Expo, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Global buyers rely on TMC’s content-driven marketplaces to make purchase decisions and navigate markets. Learn how we can help you reach your marketing goals.
SYS-CON Events announced today that Enroute Lab will exhibit at the Japan External Trade Organization (JETRO) Pavilion at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Enroute Lab is an industrial design, research and development company of unmanned robotic vehicle system. For more information, please visit http://elab.co.jp/.
Cloud-based disaster recovery is critical to any production environment and is a high priority for many enterprise organizations today. Nearly 40% of organizations have had to execute their BCDR plan due to a service disruption in the past two years. Zerto on IBM Cloud offer VMware and Microsoft customers simple, automated recovery of on-premise VMware and Microsoft workloads to IBM Cloud data centers.
Why Federal cloud? What is in Federal Clouds and integrations? This session will identify the process and the FedRAMP initiative. But is it sufficient? What is the remedy for keeping abreast of cutting-edge technology? In his session at 21st Cloud Expo, Rasananda Behera will examine the proposed solutions: Private or public or hybrid cloud Responsible governing bodies How can we accomplish?
There is huge complexity in implementing a successful digital business that requires efficient on-premise and cloud back-end infrastructure, IT and Internet of Things (IoT) data, analytics, Machine Learning, Artificial Intelligence (AI) and Digital Applications. In the data center alone, there are physical and virtual infrastructures, multiple operating systems, multiple applications and new and emerging business and technological paradigms such as cloud computing and XaaS. And then there are pe...
SYS-CON Events announced today that Daiya Industry will exhibit at the Japan External Trade Organization (JETRO) Pavilion at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Daiya Industry specializes in orthotic support systems and assistive devices with pneumatic artificial muscles in order to contribute to an extended healthy life expectancy. For more information, please visit https://www.daiyak...
Real IoT production deployments running at scale are collecting sensor data from hundreds / thousands / millions of devices. The goal is to take business-critical actions on the real-time data and find insights from stored datasets. In his session at @ThingsExpo, John Walicki, Watson IoT Developer Advocate at IBM Cloud, will provide a fast-paced developer journey that follows the IoT sensor data from generation, to edge gateway, to edge analytics, to encryption, to the IBM Bluemix cloud, to Wa...
New competitors, disruptive technologies, and growing expectations are pushing every business to both adopt and deliver new digital services. This ‘Digital Transformation’ demands rapid delivery and continuous iteration of new competitive services via multiple channels, which in turn demands new service delivery techniques – including DevOps. In this power panel at @DevOpsSummit 20th Cloud Expo, moderated by DevOps Conference Co-Chair Andi Mann, panelists examined how DevOps helps to meet the de...
Cloud Expo, Inc. has announced today that Andi Mann and Aruna Ravichandran have been named Co-Chairs of @DevOpsSummit at Cloud Expo Silicon Valley which will take place Oct. 31-Nov. 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. "DevOps is at the intersection of technology and business-optimizing tools, organizations and processes to bring measurable improvements in productivity and profitability," said Aruna Ravichandran, vice president, DevOps product and solutions marketing...
Enterprises are moving to the cloud faster than most of us in security expected. CIOs are going from 0 to 100 in cloud adoption and leaving security teams in the dust. Once cloud is part of an enterprise stack, it’s unclear who has responsibility for the protection of applications, services, and data. When cloud breaches occur, whether active compromise or a publicly accessible database, the blame must fall on both service providers and users. In his session at 21st Cloud Expo, Ben Johnson, C...
The last two years has seen discussions about cloud computing evolve from the public / private / hybrid split to the reality that most enterprises will be creating a complex, multi-cloud strategy. Companies are wary of committing all of their resources to a single cloud, and instead are choosing to spread the risk – and the benefits – of cloud computing across multiple providers and internal infrastructures, as they follow their business needs. Will this approach be successful? How large is the ...